Cover
About Us
Financial Highlights
To Our Shareholders
Operational Effectiveness
Innovating for Impact
Healthcare Worker Safety
Patient Safety
Diabetes
Infectious Diseases
HIV/AIDS
Immunization
Drug Discovery
Social Responsibility and BD
Vaccine Grants/Johns Hopkins University
Project Perfect World
U.S. Fund for UNICEF / MNT
Enterprise Profile
Financials
Notes to Consolidated Financial Statements
Financial Review
Financial Statements
Corporate Information
Board of Directors
Corporate Officers
Back Cover
Notes to Consolidated
Financial Statements
Thousands of dollars, except per-share amounts and numbers of shares
Index
Note
Subject
1
Summary of Significant Accounting Policies
2
Accounting Changes
3
Goodwill and Other Intangible Assets
4
Benefit Plans
5
Special Charges
6
Acquisitions
7
Income Taxes
8
Supplemental Financial Information
9
Debt
10
Financial Instruments
11
Shareholders’ Equity
12
Other Comprehensive Income (Loss)
13
Commitments and Contingencies
14
Stock Plans
15
Earnings Per Share
16
Segment Data
17
Litigation Settlement
18
Discontinued Operations
19
Employee Stock Ownership Plan/
Savings Incentive Plan
20
Blood Glucose Monitoring Charges
